Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mai-Zhi-Ling for post-thrombotic syndrome after lower-extremity deep vein thrombosis
ChiCTR2000032201Phase 4Recruiting
- Sponsor
- Shenzhen Second People's Hospital
- Start
- Nov 2018
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Horse chestnut seed extract in post-thrombotic syndrome (PTS) and deep vein thrombosis (DVT) (2 arms), sponsored by Shenzhen Second People's Hospital. Primary endpoint: Villalta score. Started Nov 2018; status: recruiting.
02
Drugs
Horse chestnut seed extract
03
Conditions
post-thrombotic syndrome (PTS)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on ChiCTR2000032201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032201.